CompoAtlas

Hair Skin Nails

Withdrawn from the US market on 31 October 2024 (according to the DSLD)

KLEENIQ, food supplement from the US market

Label withdrawn from the US market. Hair Skin Nails (KLEENIQ), a food supplement without a usable barcode in DSLD, is described by its US market label. If sold in France, it would be subject to 5 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

If this product were sold in France

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
KLEENIQ
Barcode
Not provided or invalid in DSLD
Form
Tablet
One serving
2 tablets
Servings
up to 1 serving per day
Other ingredients (in English, as written)
Di-Calcium Phosphate, Stearic Acid, Croscarmellose Sodium, Pharmaceutical Glaze, Vegetable Magnesium Stearate, Silicon Dioxide, Microcrystalline Cellulose
Ingredient (as written, in English)CategoryPer serving
Vitamin CVitamin400 mg
Vitamin EVitamin60 UI
Vitamin B6Vitamin4 mg
BiotinVitamin5,000 µg
Pantothenic AcidVitamin20 mg
CalciumMineral85 mg
ZincMineral20 mg
SeleniumMineral140 µg
CopperMineral1 mg
ManganeseMineral4 mg
OptiMSMOther substance250 mg
SilicaMineral12.5 mg
Hydrolyzed Collagen Type 1 & 3Protein250 mg
L-MethionineAmino acid125 mg
Citrus Bioflavonoid 50% ComplexOther substance100 mg
hydrolyzed KeratinOther50 mg
Hyaluronic AcidOther substance5 mg
Alpha Lipoic AcidOther substance50 mg
Proprietary BlendBlend367 mg
Gotu Kola 10% extract (Centella asiatica)Plantnot stated
Grape seed 95% extractPlantnot stated
Fo-Ti root powder (Reynoutria multiflora)Plantnot stated
Amla 60% extract (Phyllanthus emblica)Plantnot stated
Goji berry 40% extractPlantnot stated
Bladderwrack powder (Fucus vesiculosus)Plantnot stated
Nori yaki (Porphyra umbilicalis)Plantnot stated
Wakame powder (Undaria pinnatifida)Plantnot stated
Olive water 15% extractPlantnot stated
Natural Astaxanthin ComplexBlendnot stated

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Amla 60% extract
    Read the warning, when it applies and the studies cited

    Amla - Phyllanthus Emblica

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (HC 2009).

    Sources cited by Health Canada (1)
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html

    Applies to products providing more than 3 grams of amla, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (HC 2009).

    Sources cited by Health Canada (1)
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html

    Condition of application: Amlapitta, Digestive tonic.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Laxative.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (HC 2009; Pray 2006; CPhA 2002).

    Sources cited by Health Canada (3)
    • CPhA 2002: Repchinsky C, editor-in-chief. Patient Self-Care: Helping Patients Make Therapeutic Choices. 1st edition. Ottawa (ON): Canadian Pharmacists Association; 2002.
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
    • Pray WS. Non-Prescription Product Therapeutics. 2nd edition. New York (NY): Lippincott Williams & Wilkins; 2006.

    Contraindications

    Condition of application: Laxative.

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (HC 2009).

    Sources cited by Health Canada (1)
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html

    Known adverse reactions

    Condition of application: Amlapitta, Antioxidant, Digestive tonic, Rasayana or Eye tonic.

    When using this product you may experience a laxative effect.

    Health Canada monograph dated 28 March 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Photograph the packaging

Brand : KLEENIQ

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Hair Skin Nails : étiquette retirée du marché américain (KLEENIQ): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/dsld-246696-hair-skin-nails-kleeniq, updated 31 October 2024.

List recorded in 2021. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line